Cao Liyuan相关文献与解析，生知库 | 链接生命科学的每一步

Risk factors for acute kidney injury after coronary artery bypass graft surgery: a systematic review and meta-analysis

冠状动脉旁路移植术后急性肾损伤的危险因素：系统评价和荟萃分析

期刊:Frontiers in Medicine

影响因子:3

doi:10.3389/fmed.2026.1722801

Chu, Hongyan; Li, Shuling; Cao, Liyuan; Xu, Guangzhe; Yang, Lihua; Ma, Chun

Bibliometric analysis of research hotspots and emerging trends in microRNAs and atherosclerosis (2007-2025)

微小RNA与动脉粥样硬化研究热点及新兴趋势的文献计量分析（2007-2025）

期刊:Frontiers in Cardiovascular Medicine

影响因子:

doi:10.3389/fcvm.2026.1770481

She, Jiuhua; Yu, Yuxue; Gao, Boyan; Song, Jiayuan; Cao, Liyuan; Wang, Meiling; Yan, Xiaoli; Chang, Liping; Shi, Guijun

Macrophage polarization in diabetic vascular complications: mechanistic insights and therapeutic targets

糖尿病血管并发症中巨噬细胞极化：机制解析和治疗靶点

期刊:Journal of Translational Medicine

影响因子:7.5

doi:10.1186/s12967-025-07075-0

Cao, Liyuan; Ding, Lu; Xia, Qinjing; Zhang, Zepeng; Li, Min; Song, Siyu; Yin, Kai; Li, Zirui; Li, Xueyan; Wang, Zihan; Zhao, Daqing; Li, Xiangyan; Wang, Zeyu

Yangke powder alleviates OVA-induced allergic asthma by inhibiting the PI3K/AKT/NF-ÎºB signaling pathway.

养克粉通过抑制PI3K/AKT/NF-κB信号通路缓解OVA诱发的过敏性哮喘

期刊:Chinese Medicine

影响因子:5.7

doi:10.1186/s13020-025-01125-x

Li Xueyan, Ding Lu, Li Zirui, Cao Zhenghua, Li Min, Yin Kai, Song Siyu, Cao Liyuan, Xia Qinjing, Wang Zihan, Zhao Daqing, Tong Xiaolin, Li Xiangyan, Wang Zeyu

Corrigendum: Natural products targeting AMPK signaling pathway therapy, diabetes mellitus and its complications

更正：靶向 AMPK 信号通路疗法的天然产物、糖尿病及其并发症

期刊:Frontiers in Pharmacology

影响因子:4.8

doi:10.3389/fphar.2025.1604573

Li, Min; Ding, Lu; Cao, Liyuan; Zhang, Zepeng; Li, Xueyan; Li, Zirui; Xia, Qinjing; Yin, Kai; Song, Siyu; Wang, Zihan; Du, Haijian; Zhao, Daqing; Li, Xiangyan; Wang, Zeyu

Natural products targeting AMPK signaling pathway therapy, diabetes mellitus and its complications

靶向AMPK信号通路疗法的天然产物，用于治疗糖尿病及其并发症

期刊:Frontiers in Pharmacology

影响因子:4.8

doi:10.3389/fphar.2025.1534634

Li, Min; Ding, Lu; Cao, Liyuan; Zhang, Zepeng; Li, Xueyan; Li, Zirui; Xia, Qinjing; Yin, Kai; Song, Siyu; Wang, Zihan; Du, Haijian; Zhao, Daqing; Li, Xiangyan; Wang, Zeyu

LILRB1 enhances the progression of diffuse large B-cell lymphoma through the CREB-SORBS3 pathway.

LILRB1 通过 CREB-SORBS3 通路促进弥漫性大 B 细胞淋巴瘤的进展

期刊:Cellular Oncology

影响因子:4.8

doi:10.1007/s13402-025-01060-x

Cao Liyuan, Zhao Hanqing, Zhou Xuanyi, Yuan Jin, Weng Lietao, Yu Zhuo, Zheng Junke, Chen Chiqi

细胞生物学

发表日期：2025

文献求助收藏

Screening of an FDA-Approved Drug Library: Menadione Induces Multiple Forms of Programmed Cell Death in Colorectal Cancer Cells via MAPK8 Cascades.

FDA 批准的药物库筛选：甲萘醌通过 MAPK8 级联反应诱导结直肠癌细胞发生多种形式的程序性细胞死亡

期刊:Pharmaceuticals

影响因子:4.8

doi:10.3390/ph18081145

Cao Liyuan, Song Weiwei, Sun Jinli, Ge Yang, Mu Wei, Li Lei

BCAA catabolism mediates POU2AF1 propionylation to enhance T-ALL development.

BCAA 分解代谢介导 POU2AF1 丙酰化，从而增强 T-ALL 的发展。

IRF7 is a novel prognostic biomarker in kidney renal clear cell carcinoma

IRF7是肾透明细胞癌的一种新型预后生物标志物。

Risk factors for acute kidney injury after coronary artery bypass graft surgery: a systematic review and meta-analysis

冠状动脉旁路移植术后急性肾损伤的危险因素：系统评价和荟萃分析

Bibliometric analysis of research hotspots and emerging trends in microRNAs and atherosclerosis (2007-2025)

微小RNA与动脉粥样硬化研究热点及新兴趋势的文献计量分析（2007-2025）

Macrophage polarization in diabetic vascular complications: mechanistic insights and therapeutic targets

糖尿病血管并发症中巨噬细胞极化：机制解析和治疗靶点

Yangke powder alleviates OVA-induced allergic asthma by inhibiting the PI3K/AKT/NF-ÎºB signaling pathway.

养克粉通过抑制PI3K/AKT/NF-κB信号通路缓解OVA诱发的过敏性哮喘

Corrigendum: Natural products targeting AMPK signaling pathway therapy, diabetes mellitus and its complications

更正：靶向 AMPK 信号通路疗法的天然产物、糖尿病及其并发症

Natural products targeting AMPK signaling pathway therapy, diabetes mellitus and its complications

靶向AMPK信号通路疗法的天然产物，用于治疗糖尿病及其并发症

LILRB1 enhances the progression of diffuse large B-cell lymphoma through the CREB-SORBS3 pathway.

LILRB1 通过 CREB-SORBS3 通路促进弥漫性大 B 细胞淋巴瘤的进展

Screening of an FDA-Approved Drug Library: Menadione Induces Multiple Forms of Programmed Cell Death in Colorectal Cancer Cells via MAPK8 Cascades.

FDA 批准的药物库筛选：甲萘醌通过 MAPK8 级联反应诱导结直肠癌细胞发生多种形式的程序性细胞死亡